Your browser doesn't support javascript.
loading
Antidepressants in social anxiety disorder
Nardi, Antonio E.
Afiliación
  • Nardi, Antonio E; Federal University of Rio de Janeiro. Institute of Psychiatry. BR
Arq. neuropsiquiatr ; 59(3A): 637-642, Sept. 2001. tab
Article en En | LILACS | ID: lil-295926
Biblioteca responsable: BR1.1
RESUMO
Social anxiety disorder (SAD) is a marked and persistent fear of doing almost everything in front of people due to concerns about being judge by others. An up-to-date review is needed in order to reach a practical judgement of all psychopharmacological data. Case reports, open and double-blind trials with SAD were described and commented upon from a clinical point of view. The MEDLINE system was searched from 1975 to 2001. The references from the selected papers were also used as a source. MAOIs (fenelzine, tranylcypromine), reversible monoamino oxidase-A inhibitors (moclobemide, brofaromine), SSRIs (paroxetine, sertraline, fluoxetine, fluvoxamine) and some other antidepressants (venlafaxine, nefazodone) have proven effective in several studies with various methodologies. The MAOIs have more serious adverse effects and the SSRIs have the best tolerance. SSRIs are efficacious and the first choice of treatment
Asunto(s)
Texto completo: 1 Índice: LILACS Asunto principal: Trastornos Fóbicos / Antidepresivos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Arq. neuropsiquiatr Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2001 Tipo del documento: Article / Project document
Texto completo: 1 Índice: LILACS Asunto principal: Trastornos Fóbicos / Antidepresivos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Arq. neuropsiquiatr Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2001 Tipo del documento: Article / Project document